ProPhase Labs’ Resolution for 2025: Nail Down a ‘Liquidity Event’
The company has lost nearly $36 million since 2023, but its CEO is aggressively pursuing new revenue options
Laboratory Industry Report
Keeps You Up-to-Date on Lab Business and Competitive Strategy, Market Trends and Opportunities, and M&A and Investment Activity in Today’s Diagnostic Lab Industry
Subscribe today for access to
Articles and Reports
Out with the Old: The 2024 Clinical Lab Experience
What challenges and opportunities affected the experience of medical lab professionals in 2024—and what might the new year bring?
FDA Watch: How Could the Change in US Government Affect IVDs and Labs?
Experts say new leadership could impact the cost and availability of IVDs as well as patients’ ability to afford lab testing
ACLA Uses Cancer Initiative to Lobby on PAMA, LDTs
...
Already a member? Log in here
PAML Campaign Encourages Men to Seek Routine Testing
...
Already a member? Log in here
Healthy Financial Outlook for Publicly Traded Labs in 2016
...
Already a member? Log in here
Connecticut Lab Developing $200 BRCA Test
...
Already a member? Log in here
Children’s Hospital Los Angeles, Thermo Fisher to Develop NGS Pediatric Cancer Test Panel
From - Laboratory Industry Report
Children's Hospital Los Angeles (CHLA) has entered into a pact with Thermo Fisher Scientific to develop a panel of next-generation sequencing tests specifically for…
A Big Deal for Big Data: IBM to Acquire Truven for $2.6 Billion
From - Laboratory Industry Report
Less than a year after launching its Watson Health unit, IBM (Armonk, N.Y.) has announced a fourth major health data-related acquisition…
Walgreens Tells Theranos to Fix Problems or Lose Pact
From - Laboratory Industry Report
Walgreens has told Theranos to get its act together, or get out…
Illumina Enters Into Biobanking Deal With Four Major Health Care Providers
From - Laboratory Industry Report
San Diego-based Illumina has entered into biobanking deals with four major health care providers, allowing it to genotype tens of thousands of genetic specimens…
Abbott to Acquire Alere for $5.8 Billion in Point-of-Care Play
From - Laboratory Industry Report
Abbott (Abbott Park, Ill.) is betting big on point-of-care testing. The global healthcare giant announced on Feb. 1 its agreement to acquire Alere (Waltham, Mass.) for…
Survey Says Many Hospitals Are Reluctant to Adopt Precision
...
Already a member? Log in here